Copyright Reports & Markets. All rights reserved.

Global Preclinical Imaging (In-VIVO) Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Preclinical Imaging (In-VIVO)

      • 1.1 Definition of Preclinical Imaging (In-VIVO)
      • 1.2 Preclinical Imaging (In-VIVO) Segment by Type
        • 1.2.1 Global Preclinical Imaging (In-VIVO) Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Modality
        • 1.2.3 Reagent
        • 1.2.4 Others
      • 1.3 Preclinical Imaging (In-VIVO) Segment by Applications
        • 1.3.1 Global Preclinical Imaging (In-VIVO) Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Oncology
        • 1.3.3 Cardio and Vascular
        • 1.3.4 Neurology
        • 1.3.5 Others
      • 1.4 Global Preclinical Imaging (In-VIVO) Overall Market
        • 1.4.1 Global Preclinical Imaging (In-VIVO) Revenue (2014-2025)
        • 1.4.2 Global Preclinical Imaging (In-VIVO) Production (2014-2025)
        • 1.4.3 North America Preclinical Imaging (In-VIVO) Status and Prospect (2014-2025)
        • 1.4.4 Europe Preclinical Imaging (In-VIVO) Status and Prospect (2014-2025)
        • 1.4.5 China Preclinical Imaging (In-VIVO) Status and Prospect (2014-2025)
        • 1.4.6 Japan Preclinical Imaging (In-VIVO) Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Preclinical Imaging (In-VIVO) Status and Prospect (2014-2025)
        • 1.4.8 India Preclinical Imaging (In-VIVO) Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Preclinical Imaging (In-VIVO)
      • 2.3 Manufacturing Process Analysis of Preclinical Imaging (In-VIVO)
      • 2.4 Industry Chain Structure of Preclinical Imaging (In-VIVO)

      3 Development and Manufacturing Plants Analysis of Preclinical Imaging (In-VIVO)

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Preclinical Imaging (In-VIVO) Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Preclinical Imaging (In-VIVO)
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Preclinical Imaging (In-VIVO) Production and Capacity Analysis
      • 4.2 Preclinical Imaging (In-VIVO) Revenue Analysis
      • 4.3 Preclinical Imaging (In-VIVO) Price Analysis
      • 4.4 Market Concentration Degree

      5 Preclinical Imaging (In-VIVO) Regional Market Analysis

      • 5.1 Preclinical Imaging (In-VIVO) Production by Regions
        • 5.1.1 Global Preclinical Imaging (In-VIVO) Production by Regions
        • 5.1.2 Global Preclinical Imaging (In-VIVO) Revenue by Regions
      • 5.2 Preclinical Imaging (In-VIVO) Consumption by Regions
      • 5.3 North America Preclinical Imaging (In-VIVO) Market Analysis
        • 5.3.1 North America Preclinical Imaging (In-VIVO) Production
        • 5.3.2 North America Preclinical Imaging (In-VIVO) Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Preclinical Imaging (In-VIVO) Import and Export
      • 5.4 Europe Preclinical Imaging (In-VIVO) Market Analysis
        • 5.4.1 Europe Preclinical Imaging (In-VIVO) Production
        • 5.4.2 Europe Preclinical Imaging (In-VIVO) Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Preclinical Imaging (In-VIVO) Import and Export
      • 5.5 China Preclinical Imaging (In-VIVO) Market Analysis
        • 5.5.1 China Preclinical Imaging (In-VIVO) Production
        • 5.5.2 China Preclinical Imaging (In-VIVO) Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Preclinical Imaging (In-VIVO) Import and Export
      • 5.6 Japan Preclinical Imaging (In-VIVO) Market Analysis
        • 5.6.1 Japan Preclinical Imaging (In-VIVO) Production
        • 5.6.2 Japan Preclinical Imaging (In-VIVO) Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Preclinical Imaging (In-VIVO) Import and Export
      • 5.7 Southeast Asia Preclinical Imaging (In-VIVO) Market Analysis
        • 5.7.1 Southeast Asia Preclinical Imaging (In-VIVO) Production
        • 5.7.2 Southeast Asia Preclinical Imaging (In-VIVO) Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Preclinical Imaging (In-VIVO) Import and Export
      • 5.8 India Preclinical Imaging (In-VIVO) Market Analysis
        • 5.8.1 India Preclinical Imaging (In-VIVO) Production
        • 5.8.2 India Preclinical Imaging (In-VIVO) Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Preclinical Imaging (In-VIVO) Import and Export

      6 Preclinical Imaging (In-VIVO) Segment Market Analysis (by Type)

      • 6.1 Global Preclinical Imaging (In-VIVO) Production by Type
      • 6.2 Global Preclinical Imaging (In-VIVO) Revenue by Type
      • 6.3 Preclinical Imaging (In-VIVO) Price by Type

      7 Preclinical Imaging (In-VIVO) Segment Market Analysis (by Application)

      • 7.1 Global Preclinical Imaging (In-VIVO) Consumption by Application
      • 7.2 Global Preclinical Imaging (In-VIVO) Consumption Market Share by Application (2014-2019)

      8 Preclinical Imaging (In-VIVO) Major Manufacturers Analysis

      • 8.1 PerkinElmer
        • 8.1.1 PerkinElmer Preclinical Imaging (In-VIVO) Production Sites and Area Served
        • 8.1.2 PerkinElmer Product Introduction, Application and Specification
        • 8.1.3 PerkinElmer Preclinical Imaging (In-VIVO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Bruker Corporation
        • 8.2.1 Bruker Corporation Preclinical Imaging (In-VIVO) Production Sites and Area Served
        • 8.2.2 Bruker Corporation Product Introduction, Application and Specification
        • 8.2.3 Bruker Corporation Preclinical Imaging (In-VIVO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 FUJIFILM Holdings
        • 8.3.1 FUJIFILM Holdings Preclinical Imaging (In-VIVO) Production Sites and Area Served
        • 8.3.2 FUJIFILM Holdings Product Introduction, Application and Specification
        • 8.3.3 FUJIFILM Holdings Preclinical Imaging (In-VIVO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Mediso
        • 8.4.1 Mediso Preclinical Imaging (In-VIVO) Production Sites and Area Served
        • 8.4.2 Mediso Product Introduction, Application and Specification
        • 8.4.3 Mediso Preclinical Imaging (In-VIVO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 MILabs B.V.
        • 8.5.1 MILabs B.V. Preclinical Imaging (In-VIVO) Production Sites and Area Served
        • 8.5.2 MILabs B.V. Product Introduction, Application and Specification
        • 8.5.3 MILabs B.V. Preclinical Imaging (In-VIVO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 MR Solutions
        • 8.6.1 MR Solutions Preclinical Imaging (In-VIVO) Production Sites and Area Served
        • 8.6.2 MR Solutions Product Introduction, Application and Specification
        • 8.6.3 MR Solutions Preclinical Imaging (In-VIVO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Aspect Imaging
        • 8.7.1 Aspect Imaging Preclinical Imaging (In-VIVO) Production Sites and Area Served
        • 8.7.2 Aspect Imaging Product Introduction, Application and Specification
        • 8.7.3 Aspect Imaging Preclinical Imaging (In-VIVO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 LI-COR Biosciences
        • 8.8.1 LI-COR Biosciences Preclinical Imaging (In-VIVO) Production Sites and Area Served
        • 8.8.2 LI-COR Biosciences Product Introduction, Application and Specification
        • 8.8.3 LI-COR Biosciences Preclinical Imaging (In-VIVO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Trifoil Imaging
        • 8.9.1 Trifoil Imaging Preclinical Imaging (In-VIVO) Production Sites and Area Served
        • 8.9.2 Trifoil Imaging Product Introduction, Application and Specification
        • 8.9.3 Trifoil Imaging Preclinical Imaging (In-VIVO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Miltenyi Biotec
        • 8.10.1 Miltenyi Biotec Preclinical Imaging (In-VIVO) Production Sites and Area Served
        • 8.10.2 Miltenyi Biotec Product Introduction, Application and Specification
        • 8.10.3 Miltenyi Biotec Preclinical Imaging (In-VIVO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Preclinical Imaging (In-VIVO) Market

      • 9.1 Global Preclinical Imaging (In-VIVO) Market Trend Analysis
        • 9.1.1 Global Preclinical Imaging (In-VIVO) Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Preclinical Imaging (In-VIVO) Regional Market Trend
        • 9.2.1 North America Preclinical Imaging (In-VIVO) Forecast 2019-2025
        • 9.2.2 Europe Preclinical Imaging (In-VIVO) Forecast 2019-2025
        • 9.2.3 China Preclinical Imaging (In-VIVO) Forecast 2019-2025
        • 9.2.4 Japan Preclinical Imaging (In-VIVO) Forecast 2019-2025
        • 9.2.5 Southeast Asia Preclinical Imaging (In-VIVO) Forecast 2019-2025
        • 9.2.6 India Preclinical Imaging (In-VIVO) Forecast 2019-2025
      • 9.3 Preclinical Imaging (In-VIVO) Market Trend (Product Type)
      • 9.4 Preclinical Imaging (In-VIVO) Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Preclinical Imaging (In-VIVO) Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Preclinical Imaging (In-VIVO) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Preclinical Imaging (In-VIVO) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Preclinical Imaging (In-VIVO) market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Preclinical Imaging (In-VIVO) in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Preclinical Imaging (In-VIVO) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        PerkinElmer
        Bruker Corporation
        FUJIFILM Holdings
        Mediso
        MILabs B.V.
        MR Solutions
        Aspect Imaging
        LI-COR Biosciences
        Trifoil Imaging
        Miltenyi Biotec

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Modality
        Reagent
        Others

        Segment by Application
        Oncology
        Cardio and Vascular
        Neurology
        Others

        Buy now